Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1630013
Max Phase: Preclinical
Molecular Formula: C17H28O3
Molecular Weight: 280.41
Molecule Type: Small molecule
Associated Items:
ID: ALA1630013
Max Phase: Preclinical
Molecular Formula: C17H28O3
Molecular Weight: 280.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCC(O)C#CC#C[C@H](O)[C@H](C)O
Standard InChI: InChI=1S/C17H28O3/c1-3-4-5-6-7-8-9-12-16(19)13-10-11-14-17(20)15(2)18/h15-20H,3-9,12H2,1-2H3/t15-,16?,17-/m0/s1
Standard InChI Key: QCFGLXWKPNSWBE-QRFGZVGRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 280.41 | Molecular Weight (Monoisotopic): 280.2038 | AlogP: 2.24 | #Rotatable Bonds: 9 |
Polar Surface Area: 60.69 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.41 | CX Basic pKa: | CX LogP: 3.58 | CX LogD: 3.58 |
Aromatic Rings: 0 | Heavy Atoms: 20 | QED Weighted: 0.45 | Np Likeness Score: 1.85 |
1. Shin D, Yang JE, Lee SB, Nho CW.. (2010) SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities., 20 (24): [PMID:21050753] [10.1016/j.bmcl.2010.07.066] |
Source(1):